Previous 10 | Next 10 |
Image source: The Motley Fool. InMode Ltd. (NASDAQ: INMD) Q3 2021 Earnings Call Oct 26, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: InMode Ltd. (INMD) Q3 2021 Earnings Call Transcript
InMode Ltd. (INMD) Q3 2021 Earnings Conference Call October 26, 2021 08:30 A.M. ET Company Participants Miri Segal - President, MS-IR Moshe Mizrahy - Chairman and CEO Shakil Lakhani - President, North America Yair Malca - CFO Dr. Spero Theodorou - CMO Conference Call Participants Travis Steed...
InMode Reports Record Third Quarter 2021 Financial Results: Quarterly Revenue of $94.2M, 58% Year-Over-Year Growth; GAAP Net Income of $44.7M, 87% increase compared to Q3 2020 PR Newswire YOKNEAM, Israel, Oct. 26, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("I...
AAN,ABG,ADM,ARCC,ARCH,AUDC,BDN,CAJ,CEQP,CIT,CLS,CNC,CVLT,CZOO,DAN,ECL,ENTG,GBX,GE,GLW,GPK,HAS,HUBB,OTCPK:HYMLF,HZO,INMD,IVZ,JBLU,LLY,LMT,MMM,MMYT,MSCI,MYOV,OTCQX:NHYDY,NVS,ORAN,OXSQ,PCAR,PERI,PHM,PII,PJT,PNR,RTX,SHW,SPGI,SSTK,ST,TPB,TRTN,TRU,UBS,UPS,WM,XRX For Seeking Alpha's full earnings se...
InMode Ltd. is a global healthcare company that develops its own radio-frequency-based devices for aesthetic and medical treatments. As part of its business strategy, INMD has achieved an 85% gross margin continuously for the past 6 years. INMD reported stunning revenue growt...
INMD stock looks like one of the market's best, with incredible growth before, during, and after the novel coronavirus pandemic. But valuation has changed dramatically so far in 2021, and investors need to keep in mind the history of the medical aesthetics space. There is a real b...
On Wednesday, InMode Ltd ( NASDAQ:INMD ) shares spiked more than 12%, extending Tuesday’s gains. As a result, the stock is now up more than 21% this week after announcing better-than-expected preliminary Q3 results. InMode said it expects fiscal Q3 revenue in the rang...
Shares of InMode (NASDAQ: INMD) leaped 8.6% on Tuesday after the medical technology specialist boosted its full-year financial forecast. InMode anticipates third-quarter revenue of $93.5 million to $94 million, which would signify year-over-year growth of roughly 57%. Management...
InMode Expects Record Third Quarter 2021 Revenue of $93.5M-$94M, Raising Full-Year 2021 Revenue Guidance to $343M-$347M Conference call to be held on October 26 at 8:30 a.m. Eastern Time PR Newswire YOKNEAM, Israel, Oct. 12, 2021 /PRNewswire/ -- InMode Ltd. (...
Applied UV (NASDAQ:AUVI) +41% on KES Science & Technology assets acquisition GeoVax Labs (NASDAQ:GOVX) +24% after deal for clinical-stage cancer program NuCana (NASDAQ:NCNA) +15% receives fast track designation from the U.S. Food and Drug Administration for Acelar...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...